In December 2019, reports emerged of a cluster of cases of pneumonia of unknown cause in
Wuhan, China, culminating in the identification of a novel coronavirus on 12 January
2020, denoted as severe acute respiratory syndrome coronavirus 2 (SARSCoV-2), and the
associated disease as coronavirus disease 2019 (COVID-19) (1).

Some cases of infection in children have also been reported (2) the symptoms of pediatric
COVID-19 are mild, the decrease in lymphocytes is not obvious and severe cases are rare.
Initially, children comprised between 1% and 2% of the laboratory-confirmed SARSCoV-2
detections among people in China (3), Italy (4), and the United States (5). Initial
reports from (CDC) noted the following age distributions: 15-17 years (32%), 10-14 years
(27%), 5-9 years (15%), 1-4 years (11%), and <1 year (15%), with a median age of 11 years
(5).

Diagnosis of COVID-19 will depend on the clinical presentation of the case and on
laboratory test as well as radiological finding. The cases will be stratified according
to these collective data to different grades of severity (6). Investigations for
suspected case: CBC and radiology, to confirm diagnosis: Nasopharyngeal swab for PCR and
to assess severity: Serum ferritin, D dimer, LDH, and CRP. (7) Current treatment for
COVID-19 is mainly supportive care (8).The decision of the site of management either at
home or in hospital depends on the clinical presentation, requirement for supportive
care, potential risk factors for severe disease, and the ability of the patient to
self-isolate at home(9) (10).